InVivo Therapeutics Holdings Corp (NVIVQ)

[DDobserver]

While I can respect your perspective it does not set aside the facts of no revenues for two years minimum. Gel not being approved for two years as a combination. I just cannot arrive at the price level of support of $9-10 p/s. If you place money on the table for a gamble then I would agree but if you are a value investor and have researched the intrinsic value then this is a stock that is worth 86 cents per share.